We compared the abundance ratio between 4R and 3R tau isoforms both in aggregates and soluble extracts from post mortem human brain tissue of individuals with AD and non-AD tauopathies and characterized tau PTMs using an unbiased LC-MS/MS approach. This evidence concerns the gene MAPT and Alzheimer disease.